(Photo by Orlando Sierra / AFP / FILE PHOTO)
DOST Undersecretary Rowena Guevarra said the solidarity trials will be funded by the Philippine government through the DOST and the Department of Health (DOH).
“Ini-expect natin na mag-umpisa yung sa WHO solidarity vaccine trials mga by June (We expect the WHO solidarity vaccine trials to begin by June),” Guevarra said in a public briefing.
For the clinical trials, Guevarra explained that volunteers from areas with high rates of infections will be recruited. They will then undergo protocols approved by the Food and Drug Administration (FDA) and the country’s Ethics Review Board.
“Ang gusto nilang malaman ay yung safety at saka yung efficacy nitong ating mga iba’t-ibang brands ng bakuna (What they want to know is the safety and also the efficacy of various brands of vaccines),” she said.
Published May 8, 2021, 2:59 PM
The Task Group on Vaccine Evaluation and Selection (TG-VES) is closely coordinating with 31 vaccine manufacturers and developers for supply of coronavirus disease (COVID-19) vaccines in the country.
A staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing, capital of China, March 16, 2020. (Xinhua/Zhang Yuwei / MANILA BULLETIN)
This was disclosed by Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevara, who heads the task group, which provides recommendations on which vaccines will be considered for negotiation and procurement.
“Dahil sa limitado na kakayahan ng Pilipinas na magsagawa ng vaccine development, ang pamahalaan sa pamamagitan po ng DOST ay nakikipag-ugnayan sa ilang bilateral partners para sa vaccine development at clinical trials (Due to the limited capacity of the Philippines to conduct vaccine development, the government through DOST is coordinating with sev
3 more Chinese vaccine developers apply for COVID-19 vaccine trials in PH mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
Published May 5, 2021, 11:02 AM
The chief of the Task Group on Vaccine Evaluation and Selection (TG-VES) is not surprised by the decision of the Food and Drug Administration (FDA) to issue an emergency use authorization (EUA) to the coronavirus disease (COVID-19) vaccine developed by United States-drug company Moderna.
Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevara
“This is expected since Moderna received EUA in other countries with stringent regulatory authorities (SRAs),” Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevara said in a VIber message to the Manila Bulletin on Wednesday, May 5.
DOST Secretary Fortunato “Boy” T. de la Peña also cheered at the FDA’s EUA grant to the Moderna’s coronavirus jab.
Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevara (Manila Bulletin File Photo)
Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevara, who leads the TG-VES, said more vaccine manufacturers were expected to file their EUA application before the Food and Drug Administration (FDA).
“Two or three more,” she told the Manila Bulletin in a Viber message when asked on the number of vaccine developers that will apply for EUA of their COVID-19 vaccines.
She said while, they were expecting more applicants, “we might not have any EUA approvals this month.”
Guevara noted that it takes longer than one week for the FDA to process EUA applications.